# K962494: Perioglas - Bioglass Bone Graft Particulate

- Pathway: 510(k) (Traditional)
- Applicant: Usbiomaterials Corp.
- Decided: Sep 20, 1996 after 86 days
- Product code: LYC (Bone Grafting Material, Synthetic)
- Device class: 2
- Regulation: 21 CFR 872.3930
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K941780 (1995). 2 ancestors in all.
158 later devices descend from it; 7 cite it directly.
0 of 161 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K952922: Biogran Bioactive Glass Synthetic Bone Graft Material, Orthovita Co. (1995) Summary page 1.
- K941780: Orthovita Biogran, Orthovita Co. (1995) Summary page 1.
- (no number) Hapset™: named in the summary without a submission number
- (no number) Osteogen®: named in the summary without a submission number
- (no number) Periograf®: named in the summary without a submission number

## Most influential descendants
- K033994: Novabone-BBG-Resorbable Bone Graft Substitute (2004), 85 descendants of its own
- K041613: Novabone - AR - Resorbable Bone Graft Substitute (2004), 84 descendants of its own
- K040278: Perioglas-Bioglass Bone Graft Substitute (2004), 80 descendants of its own
- K082672: Novabone Putty-Bioactive Synthetic Bone Graft (2008), 59 descendants of its own
- K101860: Novabone Putty- Bioactive Synthetic Bone Graft (2010), 47 descendants of its own

## Indications for use
Perioglaso is indicated for use in infraboney pockets caused by periodontal disease. The intended uses have been extended to extraction sites and ridge augmentation

Source page: https://510kreport.com/device/K962494
Methodology: https://510kreport.com/methodology